Research
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
1 Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Brussels, Belgium
2 Department of Anaesthesiology of the University Hospital, RWTH, Pauwelsstrasse 30, 52074 Aachen, Germany
3 Department of Emergency Medicine and Surgery and Department of Anesthesiology and Critical Care, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, 47–83 Boulevard de l'Hôpital, 75651 Paris, France
4 Service d'Anesthésie-Réanimation Chirurgicale, Hôpital Cochin, Assistance publique-Hôpitaux de Paris, Faculté de Medecine, Paris-V, Université Rene-Descartes, 27 Rue du faubourg Saint-Jacques, 75679 Paris, France
5 European Resuscitation Council, ERC Secretariat, Universiteitsplein 1, 2610 Antwerp, Belgium
6 Department of Anaesthesiology, University Hospital Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Critical Care 2006, 10:R120 doi:10.1186/cc5026
Published: 18 August 2006Additional files
Additional file 1:
A Word file listing ongoing rFVIIa studies.
Format: DOC Size: 21KB Download file
This file can be viewed with: Microsoft Word Viewer
